Sewon Cellontech signs exclusive Asia-Pacific supply deal with J&J MedTech

Sewon Cellontech (CG Bio) signed an exclusive supply agreement with Johnson & Johnson MedTech for its Novosis bone graft products in six Asia-Pacific countries, with export value over KRW 25 billion over five years.

“존슨앤드존슨(J&J) 메드테크와 자사 골대체제 '노보시스' 제품군의 아시아태평양 지역 독점 공급 계약을 체결했습니다”mt.co.kr

• 1 source
• mt.co.krJ&J 독점 계약 따낸 시지바이오…"매출 1조3000억 목표" - 머니투데이박미주 기자Feb 17, 2025

Summarized from public sources; check the original articles before acting on it.